The 10-day moving average for BMRN crossed bearishly below the 50-day moving average on September 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 72%.
The Momentum Indicator moved below the 0 level on September 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMRN as a result. In 55 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 65%.
BMRN moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMRN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
The Aroon Indicator for BMRN entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BMRN's RSI Indicator exited the oversold zone, 23 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMRN advanced for three days, in 166 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.
BMRN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. BMRN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.674) is normal, around the industry mean (2.978). BMRN's P/E Ratio (147.757) is considerably higher than the industry average of (-0.692). Projected Growth (PEG Ratio) (0.348) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (134.267) among similar stocks. P/S Ratio (3.727) is also within normal values, averaging (438.009).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The RSI Indicator for PWS moved out of oversold territory on September 17, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 23 of the 31 cases the stock moved higher. This puts the odds of a move higher at 74%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 32 of 54 cases where PWS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 59%.
Following a +1.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where PWS advanced for three days, in 191 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
PWS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PWS as a result. In 62 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.
The Moving Average Convergence Divergence Histogram (MACD) for PWS turned negative on October 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 28 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
PWS moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PWS crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PWS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
The Aroon Indicator for PWS entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
BMRN | ||
|---|---|---|
OUTLOOK RATING 1..100 | 54 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 89 | |
PRICE GROWTH RATING 1..100 | 50 | |
P/E GROWTH RATING 1..100 | 1 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BMRN | PWS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 77% | 1 day ago 74% |
| Stochastic ODDS (%) | 1 day ago 70% | 1 day ago 59% |
| Momentum ODDS (%) | 5 days ago 65% | 1 day ago 69% |
| MACD ODDS (%) | N/A | 1 day ago 78% |
| TrendWeek ODDS (%) | 1 day ago 64% | 1 day ago 68% |
| TrendMonth ODDS (%) | 1 day ago 63% | 1 day ago 66% |
| Advances ODDS (%) | 5 days ago 59% | 15 days ago 63% |
| Declines ODDS (%) | 1 day ago 61% | 19 days ago 72% |
| BollingerBands ODDS (%) | 1 day ago 70% | 1 day ago 68% |
| Aroon ODDS (%) | 1 day ago 65% | 1 day ago 65% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BMRN’s FA Score shows that 1 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BMRN’s TA Score shows that 4 TA indicator(s) are bullish.
BMRN (@Biotechnology) experienced а -1.30% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -7.86%. For the same industry, the average monthly price growth was -18.66%, and the average quarterly price growth was -19.56%.
BMRN is expected to report earnings on Nov 03, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AVGG | 19.68 | 0.67 | +3.54% |
| Leverage Shares 2X Long AVGO Daily ETF (AVGG) | |||
| KSA | 35.14 | 0.04 | +0.11% |
| iShares MSCI Saudi Arabia ETF (KSA) | |||
| MOTO | 60.02 | N/A | N/A |
| Guinness Atkinson Smart Transportation & Technology ETF (MOTO) | |||
| FSEC | 42.08 | -0.12 | -0.28% |
| Fidelity Investment Grade Securitized ETF (FSEC) | |||
| KGLD | 25.24 | -0.15 | -0.59% |
| Kurv Gold Enhanced Income ETF | |||
A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with VRTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then VRTX could also see price increases.
| Ticker / NAME | Correlation To BMRN | 1D Price Change % | ||
|---|---|---|---|---|
| BMRN | 100% | -0.02% | ||
| VRTX - BMRN | 42% Loosely correlated | +0.44% | ||
| AXON - BMRN | 42% Loosely correlated | -1.84% | ||
| IBO - BMRN | 42% Loosely correlated | +14.18% | ||
| VRDN - BMRN | 40% Loosely correlated | +9.30% | ||
| MIRM - BMRN | 37% Loosely correlated | +2.62% | ||
More | ||||
A.I.dvisor tells us that PWS and RNA have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PWS and RNA's prices will move in lockstep.
| Ticker / NAME | Correlation To PWS | 1D Price Change % | ||
|---|---|---|---|---|
| PWS | 100% | -1.00% | ||
| RNA - PWS | 22% Poorly correlated | -0.78% | ||
| Q - PWS | 21% Poorly correlated | +3.19% | ||
| KNSA - PWS | 20% Poorly correlated | +1.13% | ||
| SVRA - PWS | 20% Poorly correlated | +4.04% | ||
| BMRN - PWS | 19% Poorly correlated | -0.02% | ||
More | ||||